Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings preview of WBA stock now.

Walgreens Boots Alliance (WBA) to be acquired by Sycamore Partners at $11.45/share plus potential extras. Explore shareholder options and expert insights.

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

US Stock futures ticked higher early Thursday, with the S&P 500 now just shy of its all-time high, gaining 0.3% in pre-market trading. The Nasdaq 100 futures rose 0.4%, while Dow Jones futures added ...

The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.

Walgreens Boots Alliance (WBA) is set to report its 2025 third-quarter earnings on June 26, and Wall Street is forecasting earnings of $0.33 per share with revenue of around $36.8 billion.

Walgreens Boots Alliance (NASDAQ:WBA) reported stronger-than-expected earnings and revenue for its fiscal third quarter, as cost-cutting measures helped offset weakness in front-of-store sales. The ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2025, which ended May 31, 2025.